# Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer

> **NCT02244632** · PHASE1,PHASE2 · COMPLETED · sponsor: **Isofol Medical AB** · enrollment: 105 (actual)

## Conditions studied

- Colorectal Neoplasm

## Interventions

- **DRUG:** Modufolin (arfolitixorin)
- **DRUG:** Fluorouracil
- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT02244632
- **Lead sponsor:** Isofol Medical AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02244632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02244632, "Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02244632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*